Research Article

Beyond Single Diagnosis: Exploring Multidiagnostic Realities in Pediatric Patients through Genome Sequencing

Table 3

Genotype-phenotype correlation in cases positive for presumed multiple genetic diagnoses.

Study IDSubmitted clinical presentationPrior genetic testingMolecular mechanismDx/related featuresOverlapping/distinctive

PKIG00165 [7]9-month-old male with severe growth and developmental delay, failure to thrive, Romano-Ward syndrome, hx of G-tube feeding, metabolic disorder, mitochondrial metabolic disorder, agenesis of corpus callosum, seizure disorder, hypertension, irregular breathing pattern, hypoxia, lactic acidosis, acute respiratory failure with hypoxia and hypercapnia, respiratory distress, respiratory insufficiency, half-sibling with autismExternal WES: KCNH2 variant and SLC25A19 variants reportedKCNH2 c.774_789del p.?, heterozygous, pathogenicLong QT syndrome 2; short QT syndrome 1/Romano-Ward syndromeDistinctive
SLC25A19 c.115A>T p.(Ile39Phe), heterozygous, VUSMicrocephaly, Amish type; thiamine metabolism dysfunction syndrome 4/severe growth and developmental delay, lactic acidosis
SLC25A19 c.433C>A p.(Arg145Ser), heterozygous, VUS

PKIG002178-year-old-female with mixed conductive and sensorineural hearing loss, short stature, bilateral hypermetropia, bilateral 5th finger brachydactyly, bilateral little finger clinodactyly, hoarseness. Clinical features manifested at 6 monthsExternal panel testing: MYO3A VUS reportedANKRD11 c.2288_2289del p.?, heterozygous, pathogenicKBG syndrome/short stature, bilateral 5th finger brachydactyly, bilateral little finger clinodactylyDistinctive
TNC c.5692G>A p.(Val1898Ile), heterozygous, VUSDeafness 56/hearing loss

PKIG0025214-year-old male with small pituitary gland, delayed motor development, delayed language development, nonverbal, profound intellectual disability, chorea, congenital muscular hypotonia, focal seizure, chronic encephalopathy, esotropia, inguinal hernia, self-injurious behavior. Clinical features manifested around 5 monthsExternal karyotype, aCGH, myotonic dystrophy testing, Angelman/Prader-Willi syndrome methylation analysis, fragile X testing: nondiagnosticCACNA1A c.2042_2043del p.?, heterozygous, pathogenicEarly infantile epileptic encephalopathy 42; episodic ataxia, type 2; familial hemiplegic migraine 1; spinocerebellar ataxia 6/delayed motor development, delayed language development, profound intellectual disability, chorea, hypotonia, seizure, encephalopathyOverlapping features: delayed motor development, delayed language development, profound intellectual disability, hypotonia, seizure, encephalopathy
GABBR2 c.1724C>A p.(Thr575Asn), heterozygous, VUSEarly infantile epileptic encephalopathy 59; neurodevelopmental disorder with poor language and loss of hand skills/delayed motor development, delayed language development, nonverbal, profound intellectual disability, hypotonia, seizure, encephalopathy, self-injurious behavior

PKIG003017-year-old female with delayed motor development, delayed language development, intellectual disability, ataxia, muscular hypotonia, microcephaly, blepharospasm, ptosis, visual impairment, external ear malformation, postaxial polydactyly in hands, constipation, failure to thrive, short stature, congenital malformation of face and neck, aphasia. Clinical features manifested at 2 monthsExternal karyotype: 3p25.3p26.1 deletion and 12p13.31 deletion of unknown significance reported1.9 Mb del of 3p26.1p25.2, heterozygous, pathogenic3p- syndrome/delayed motor development, delayed language development, intellectual disability, microcephaly, ptosis, hypotonia, postaxial polydactylyOverlapping feature: delayed motor development, delayed language development, intellectual disability, microcephaly, hypotonia
GRIN2B c.1427A>G p.(Tyr476Cys), heterozygous, VUSDevelopmental and epileptic encephalopathy 27; intellectual developmental disorder 6 with or without seizures/delayed motor development, delayed language development, intellectual disability, microcephaly, hypotonia

PKIG0043918-year-old male with immunodeficiency, schizophrenia, dystonia, stroke like symptoms, ADHD, developmental delay, developmental regression, intellectual disability, ataxia, muscular hypotonia, encephalopathy, headache/migraine, abnormal creatine kinase, hyperalaninemia, increased serum pyruvate, ketosis, visual impairment, abnormal skeletal system, abnormal vertebral column, joint hypermobility, scoliosis, abnormal nail, constipation, failure to thrive, vomiting, polyhydramnios. Clinical features manifested at 3.5 years and schizophrenia manifested at 18 yearsNoneGATA2 c.1017+572C>T p.?, heterozygous, pathogenicEmberger syndrome; immunodeficiency 21/immunodeficiencyDistinctive
KDM6B c.1069G>A p.(Gly357Arg), heterozygous, VUSNeurodevelopmental disorder with coarse facies and mild distal skeletal abnormalities/developmental delay, ADHD, developmental regression, intellectual disability, hypotonia, joint hypermobility

PKIG004836-year-old male with intellectual disability, large stem, abnormal legs and hands, speech problemNone188.8 kb intragenic del of DYM exons 6-13, heterozygous, pathogenicDyggve-Melchior-Clausen disease; Smith-McCort dysplasia/large stem, abnormal legs and handsDistinctive
5.1 kb intragenic del of DYM exon 13, homozygous, pathogenic
PTCHD1 c.1636C>G p.(Gln546Glu), hemizygous, VUSSusceptibility to autism 4/intellectual disability, speech problem

PKIG010191-month-old female with multiple congenital anomalies, pyelectasis, cataract, coloboma, microphthalmia, visual impairment, high arched palate, hyperbilirubinemia, neonatal jaundice, hydronephrosis, abnormal renal morphology, bilateral single transverse palmar creases, respiratory insufficiency, aberrant right coronary artery, suspected Alagille syndromeNone11.7 Mb del of 14q31.2q32.12, heterozygous, pathogenicBilateral single transverse palmar creasesDistinctive
RAB23 c.-66+4614dup p.?, heterozygous, VUSCarpenter syndrome/visual impairment, high arched palate, pyelectasis
RAB23 c.434T>A p.(Leu145Ter), heterozygous, pathogenic

PKIG01287 [7]3-year-old female with ataxia, seizure, encephalopathy, hypertelorism, flat nasal bridge, wide nasal tip; differentials include spinocerebellar ataxia, ataxia telangiectasia, Friedreich ataxia, episodic ataxia, mitochondrial disorders, and inborn errors of metabolism (organic acidemia, urea cycle defect, maple syrup urine disease, CoQ10 deficiency). Clinical features manifested at 35 monthsNone1.5 Mb dup of 16p13.10, likely pathogenic16p13.11 microduplication syndrome/seizureDistinctive
PC c.2000A>G p.(Lys667Arg), homozygous, VUSPyruvate carboxylase deficiency/seizure, encephalopathy

PKIG0170316-month-old female with failure to thrive, hypotonia, global developmental delay, constipation, trigonocephaly, bitemporal narrowing, short nose, anteverted nares, simplified philtrum, low-set ears, joint hypermobilityExternal CMA, hypotonia panel testing (incl. myotonic dystrophy, SMA, and Prader-Willi syndrome), and fragile X testing: nondiagnosticPPM1D c.1224dup p.?, heterozygous, likely pathogenicJansen de Vries syndrome/failure to thrive, hypotonia, global developmental delay, constipation, anteverted nares, low-set earsDistinctive
SCAPER c.1382A>T p.(Asp461Val), heterozygous, VUSIntellectual developmental disorder and retinitis pigmentosa/global developmental delay
SCAPER c.1250C>T p.(Ser417Phe), heterozygous, VUS

PKIG018476-year-old male with Pierre Robin sequence, spasticity, spastic diplegic cerebral palsy, developmental delay, arthrogryposis of lower extremities, redundant nuchal skin, bilateral transverse palmar crease, hair tuft on lower back, tethered spinal cord, focal epilepsy, congenital velopharyngeal insufficiency, toe-walking, myalgias, self-injurious behavior, sleep disturbance, short stature, attention deficit hyperactivity disorder. Clinical features present at birthExternal CMA: nondiagnostic
External Stickler syndrome panel testing: COL11A1 VUS reported
WAC c.265_266del p.?, heterozygous, pathogenicDesanto-Shinawi syndrome/developmental delay, epilepsy, attention deficit hyperactivity disorder, self-injurious behaviorDistinctive
11.9 kb intragenic del of PIEZO2 intron 2, heterozygous, VUSDistal arthrogryposis type 3; distal arthrogryposis type 5; distal arthrogryposis with impaired proprioception and touch/arthrogryposis of lower extremities, Pierre Robin sequence, developmental delay, epilepsy, bilateral transverse palmar crease

PKIG01887 [7]3-year-old female with global developmental delay, delayed motor development, delayed language development, developmental regression, intellectual disability, muscular hypotonia, spasticity, epileptic activity, microcephaly, difficulty chewing, difficulty swallowing, poor sucking, severe constipation, gastroesophageal reflux disease, allergies, behavioral issues, grinding, hand biting, repetitive behavior, hyperopia, ankyloglossia. Clinical features manifested at 9 monthsExternal WES: G6PD variant unrelated to phenotype reported24.0 kb intragenic del of MECP2 exon 3, heterozygous, pathogenicNeonatal severe encephalopathy; syndromic intellectual developmental disorder 13; syndromic intellectual developmental disorder, Lubs type; Rett syndrome/global developmental delay, delayed motor development, delayed language development, developmental regression, intellectual disability, muscular hypotonia, spasticity, epileptic activity, microcephaly, difficulty chewing, difficulty swallowing, poor sucking, severe constipation, Gastroesophageal reflux disease, behavioral issues, grinding, hand biting, repetitive behaviorOverlapping features: global developmental delay, delayed motor development, delayed language development, developmental regression, intellectual disability, muscular hypotonia, spasticity, epileptic activity, microcephaly
DNM1 c.352G>C p.(Val118Leu), heterozygous, VUSDevelopmental and epileptic encephalopathy 31A; developmental and epileptic encephalopathy 31B/global developmental delay, delayed motor development, delayed language development, developmental regression, intellectual disability, muscular hypotonia, spasticity, epileptic activity, microcephaly

PKIG020376-year-old female with focal epilepsy and epileptic syndromes with simple partial seizures, intractable, without status epilepticus, refractory epilepsy, autistic disorder, gray matter and periventricular heterotopia, absent speech, intellectual disability, global developmental delay, optic nerve dysplasia, cortical visual impairment, neurogenic bladder cleft palate, congenital hypotonia, conductive hearing loss, recurrent infections, motor stereotypies, tethered cord syndrome, visual-spatial disorder, toe walking. Clinical features manifested in infancyExternal aCGH, Angelman panel test: nondiagnostic
External mtDNA: MT-TL variant reported
External WES: DMXL2 variants and SHANK3 variant reported
MT-TL1 m.3243A>G, heteroplasmic, pathogenicMitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (MELAS)/epilepsy, hypotoniaDistinctive, overlapping features: epilepsy, hypotonia
DMXL2 c.7268G>T p.(Arg2423Ile), heterozygous, VUSDevelopmental and epileptic encephalopathy 81/epilepsy, absent speech, intellectual disability, global developmental delay, hypotonia
DMXL2 c.5974G>A p.(Asp1992Asn), heterozygous, VUS

PKIG020592-year-old male with developmental delay, speech regression, gross motor delay, hypotonia, neutropenia, dysphagia for liquids, supraventricular tachycardia, possible hypothyroidism, progressive sleepiness. Cardiology phenotypes manifested at 1 monthNoneCOQ8A c.1651G>A p.(Glu551Lys), heterozygous, likely pathogenicPrimary coenzyme Q10 deficiency 4/developmental delay, speech regression, gross motor delay, hypotoniaOverlapping features: developmental delay, speech regression, gross motor delay, hypotonia
COQ8A c.901C>T p.(Arg301Trp), heterozygous, likely pathogenic
CIC c.298G>A p.(Ala100Thr), heterozygous, VUSIntellectual developmental disorder 45/developmental delay, speech regression, gross motor delay, hypotonia

Abbreviations: Dx: diagnosis; ADHD: attention deficient hyperactivity disorder; CMA: chromosomal microarray; aCGH: array comparative genomic hybridization; SNP: single nucleotide polymorphism; VUS: variant of uncertain significance. Note: for comprehensive case-level information, including HPO terms, variant nomenclature, and other details, please refer to Table S5 in the supplement.